2003/542/EC: Commission Decision of 17 July 2003 amending Decision 2000/96/EC as regards the operation of dedicated surveillance networks (Text with EEA relevance) (notified under document number C(2003) 2522)
Date: 2003-07-17
Institutions: European Commission
Subjects: disease prevention, epidemiology, health control, infectious disease, information network

24.7.2003

EN

Official Journal of the European Union

L 185/55

amending Decision 2000/96/EC as regards the operation of dedicated surveillance networks

COMMISSION DECISION

of 17 July 2003

(notified under document number C(2003) 2522)

(Text with EEA relevance)

(2003/542/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

HAS ADOPTED THIS DECISION:

Having regard to the Treaty establishing the European
Community,

Having regard to Decision No 2119/98/EC of the European
Parliament and of the Council of 24 September 1998 setting
up a network for the epidemiological surveillance and control
of communicable diseases in the Community (1), and in parti-
cular of Article 3(a), (b), (c), (d) and (e) thereof,

Whereas:

(1)

(2)

(3)

(4)

(5)

Commission Decision No 2000/96/EC of 22 December
1999 on the communicable diseases to be progressively
covered by the Community network under Decision No
2119/98/EC of
the
Council (2) lists the communicable diseases and special
health issues to be progressively covered by epidemiolo-
gical surveillance.

the European Parliament and of

It is necessary to specify those communicable diseases
and special health issues for which dedicated surveillance
networks have already been put in place in order to
ensure the effective operation of those networks and that
the designated structures/authorities are aware of their
responsibilities.

Each Member State should nominate contact points,
which may be institutions, services, departments or
other bodies, to ensure that the Community network is
informed regularly and without delay of events, data,
statistics,
and information regarding communicable
diseases and special health issues covered by dedicated
surveillance networks. One of those contact points or
another appropriate body should act as a coordinating
structure.

the dedicated surveillance
Operating procedures of
network should be communicated to the Community
network in order to improve comparability and compat-
ibility of data.

The measures provided for in this Decision are in accor-
dance with the opinion of the Committee set up by
Article 7 of Decision No 2119/98/EC,

Article 1

Decision 2000/96/EC is amended as follows:

1. In Article 4 the present text becomes paragraph 1 and the

following paragraph 2 is added:
‘2.
The communicable diseases and special health issues
for which a dedicated surveillance network has been put in
place are marked with an asterisk in Annex I.

Member States shall,
through their designated structures
and/or authorities, specify a contact point for each dedicated
surveillance network, delegated to be their national repre-
sentative to provide data and information in accordance
with Articles 3 and 4 of Decision No 2119/98/EC.

Each dedicated surveillance network will collect relevant
surveillance data and information, will ensure coordination
within its structure, and will without delay communicate
them to the Community network.

The dedicated surveillance network will also provide the
Community network with its operating procedures, addres-
sing at least the topics listed in Annex III.’

2. The Annexes to Decision 2000/96/EC are amended as set

out in the Annex to this Decision.

Article 2

This Decision is addressed to the Member States.

Done at Brussels, 17 July 2003.

For the Commission

David BYRNE

Member of the Commission

(1) OJ L 268, 3.10.1998, p. 1.
(2) OJ L 28, 3.2.2000, p. 50.

L 185/56

EN

Official Journal of the European Union

24.7.2003

ANNEX

The Annexes to Decision 2000/96/EC are amended as follows:

1. Annex I is replaced by the following:

‘ANNEX I

1.

COMMUNICABLE DISEASES AND SPECIAL HEALTH ISSUES TO BE PROGRESSIVELY COVERED
BY THE COMMUNITY NETWORK AS REFERRED TO IN ARTICLE 1

1.1.

For the communicable diseases and special health issues listed in this Annex, epidemiological surveil-
lance within the Community network is to be performed by the standardised collection and analysis
of data in a way that is to be determined for each communicable disease and special health issue when
specific dedicated surveillance networks are put in place.

2.

DISEASES

2.1. Diseases preventable by vaccination

Diphtheria

Infections with Haemophilus influenza group B (*)

Influenza (*)

Measles (*)

Mumps

Pertussis (*)

Poliomyelitis

Rubella

Smallpox

Tetanus

2.2.

Sexually-transmitted diseases

Chlamydia infections

Gonococcal infections

HIV-infection (*)

Syphilis

2.3. Viral hepatitis

Hepatitis A

Hepatitis B

Hepatitis C

2.4.

Food- and water-borne diseases and diseases of environmental origin

Anthrax

Botulism

Campylobacteriosis

Cryptosporidiosis

Giardiasis

Infection with Enterohaemorrhagic E. coli (*)

Leptospirosis

(*) Those communicable diseases and special health issues for which a dedicated surveillance network is in place are marked with an

asterisk.

24.7.2003

EN

Official Journal of the European Union

L 185/57

Listeriosis

Salmonellosis (*)

Shigellosis

Toxoplasmosis

Trichinosis

Yersinosis

2.5. Other diseases

2.5.1. Diseases transmitted by non-conventional agents

Transmissible spongiform encephalopathies, variant Creutzfeldt-Jakob's disease (*)

2.5.2. Air-borne diseases

Legionellosis (*)

Meningococcal disease (*)

Pneumococcal infections

Tuberculosis (*)

2.5.3. Zoonoses (other than those listed in 2.4)

Brucellosis

Echinococcosis

Rabies

Q-fever

Tularaemia

2.5.4. Serious imported diseases

Cholera

Malaria

Plague

Viral haemorrhagic fevers (*)

3.

SPECIAL HEALTH ISSUES

3.1. Nosocomial infections

3.2. Antimicrobial resistance (*)’

2. The following Annex III is added:

TOPICS TO BE ADDRESSED BY OPERATING PROCEDURES OF DEDICATED SURVEILLANCE
NETWORKS TO BE SUBMITTED TO THE COMMUNITY NETWORK AS REFERRED TO IN ARTICLE 4.2

‘ANNEX III

1. Coordinating structure and decision-making process.

2. Project management administration and supervision.

3. Case definitions, nature, and type of data to be collected.

4. Data management and protection, including data access and confidentiality.

(*) Those communicable diseases and special health issues for which a dedicated surveillance network is in place are marked with an

asterisk.

L 185/58

EN

Official Journal of the European Union

24.7.2003

5. Ways in which data are made comparable and compatible (quality requirements and data validation).

6. Appropriate technical means and the procedures by which the data are to be disseminated and analysed at

Community level (data dissemination and reporting).

7. Proposed public health action, infection control procedures, and laboratory procedures.’